For patients with chronic pain, opioid use disorder (OUD) is characterized by difficulties in positive emotion regulation (ER), and mindfulness training can enhance positive ER.

Nirsevimab is effective for reducing the burden of respiratory syncytial virus (RSV) in infants in real-world settings.

Nontobacco nicotine use in US youth shifted from 2023 to 2024 toward greater use of nicotine pouches, according to a study.

Enforcing drug distribution laws in San Francisco inadvertently increases opioid overdose mortality, suggesting a different strategy is necessary.

From 2018 to 2021, the role of psychotherapy in outpatient mental health care increased, while psychotropic medication without psychotherapy became less common.

Internal restlessness was associated with more alcohol consequences, with students reporting strong coping and enhancement motives.

In the US, prescription stimulant misuse and PSUD are highly prevalent, suggesting a need for clinical-guidance and training on benefits and risks.

Daily variation in continuous glucose monitoring metrics was associated with cognitive performance among patients with type 1 diabetes.

Hospital-onset antimicrobial-resistant infections increased across U.S. hospitals during and beyond the COVID-19 pandemic.

For mothers with opioid use disorder (OUD), treatment with buprenorphine in pregnancy is associated with improved maternal and infant outcomes.

Emotional dysregulation and personality accounted for some of the heterogeneity in college students and their self-reported ADHD experiences.